miR-206 inhibits renal cell cancer growth by targeting GAK

Abstract

Renal cell cancer (RCC) remains one of the most lethal types of cancer in adults. MicroRNAs (miRNAs) play key roles in the pathogenesis of RCC. The role of miR-206 in RCC has not been fully understood. The purpose of this study was to examine the role of miR-206 in the regulation of proliferation and metastasis of RCC and the possible mechanism. miR-206 expression was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in RCC cell lines (786-O and OS-RC-2 cells) and clinical samples. MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] method, colony formation and transwell assay were used to detect the tumor-suppressing ability of miR-206 in RCC. Luciferase assay was performed to verify the precise target of miR-206. The results showed that the expression of miR-206 was significantly down-regulated in RCC tissues and cells. The expression level of cyclin G-associated kinase (GAK), a master regulator of tumor proliferation and metastasis, was up-regulated with the decrease in miR-206 in RCC tissues as well as RCC cell lines. In addition, the miR-206 inhibitor promoted the proliferation, migration and invasion of 786-O and OS-RC-2 cells. Bioinformatics combined with luciferase and Western blot assays revealed that miR-206 inhibited the expression of GAK. Moreover, miR-206 regulates RCC cell growth partly through targeting GAK. Our study indicated that miR-206 functions as a tumor suppressor in regulating the proliferation, migration and invasion of RCC by directly targeting GAK, and it holds promises as a potential therapeutic target for RCC.

Keywords

miR-206 / renal cell cancer / G-associated kinase

References

[1] AkhavanA, RichardsM, ShnorhavorianM, et al. . Renal cell carcinoma in children, adolescents and young adults: a National Cancer Database study. J urol, 2015, 193(4): 1336-1341 PMID: 25451825

[2] KapoorA. What’s new in renal cell cancer research? Highlights of GU-ASCO 2015. Can Urol Assoc J, 2015, 9: S154-S155 PMID: 26221195 PMCID: 4497356

[3] WhiteNM, YousefGM. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med, 2010, 8: 65 PMID: 20964839 PMCID: 2978114

[4] PantuckAJ, ZismanA, BelldegrunAS. The changing natural history of renal cell carcinoma. J Urol, 2001, 166(5): 1611-1623 PMID: 11586189

[5] QinX, ZhangH, YeD, et al. . B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. Onco Targets Ther, 2013, 6: 1667-1673 PMID: 24265557 PMCID: 3833620

[6] BartelDP. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136(2): 215-233 PMID: 19167326 PMCID: 3794896

[7] LiWY, ChenXM, XiongW, et al. . Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(5): 640-645 PMID: 25318871

[8] ZhangY, KimJ, MuellerAC, et al. . Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma. Cell Death Differ, 2014, 21(5): 720-734 PMID: 24440911 PMCID: 3978301

[9] YinJ, ParkG, LeeJE, et al. . DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis. Brain, 2015, 138: 2553-2570 PMID: 26121981

[10] LiX, LiuY, GranbergKJ, et al. . Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene, 2015, 34(13): 1619-1628 PMID: 24747968

[11] DaiS, WangX, LiX, et al. . MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme. Biochem Biophys Res Commun, 2015, 467(2): 204-210 PMID: 26449464

[12] SunP, SunD, WangX, et al. . miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer. Cancer Biomark, 2015, 15(4): 391-396 PMID: 26406866

[13] GeX, LyuP, CaoZ, et al. . Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Biochem Biophys Res Commun, 2015, 463(4): 1115-1121 PMID: 26093295

[14] PanwalkarP, MoiyadiA, GoelA, et al. . MiR-206, a cerebellum enriched miRNA is downregulated in all medulloblastoma subgroups and its overexpression is necessary for growth inhibition of medulloblastoma cells. J Mol Neurosci, 2015, 56(3): 673-680 PMID: 25859932

[15] YuWF, WangHM, LuBC, et al. . miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2. Eur Rev Med Pharmacol Sci, 2015, 19(14): 2697-2702 PMID: 26221902

[16] ZhangL, XiaL, ZhaoL, et al. . Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis. Carcinogenesis, 2015, 36(3): 390-399 PMID: 25653235

[17] KanaokaY, KimuraSH, OkazakiI, et al. . GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain. FEBS Lett, 1997, 402(1): 73-80 PMID: 9013862

[18] GreenerT, ZhaoX, NojimaH, et al. . Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells. J Biol Chem, 2000, 275(2): 1365-1370 PMID: 10625686

[19] ZhangCX, Engqvist-GoldsteinAE, CarrenoS, et al. . Multiple roles for cyclin G-associated kinase in clathrin-mediated sorting events. Traffic, 2005, 6(12): 1103-1113 PMID: 16262722

[20] SakuraiMA, OzakiY, OkuzakiD, et al. . Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630. PLoS One, 2014, 9(6): 100124

[21] SunW, LvW, LvH, et al. . Genome-wide haplotype association analysis identifies SERPINB9, SERPINE2, GAK, and HSP90B1 as novel risk genes for oral squamous cell carcinoma. Tumour Biol, 2016, 37(2): 1845-1851 PMID: 26318431

[22] SusaM, ChoyE, LiuX, et al. . Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking. Mol Cancer Ther, 2010, 9(12): 3342-3350 PMID: 20881269

[23] ZoniE v d, HorstG v, de MerbelAF, et al. . miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of alphav-and alpha6-integrin expression. Cancer Res, 2015, 75(11): 2326-2336 PMID: 25858144

[24] QueT, SongY, LiuZ, et al. . Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene, 2015, 34(38): 4952-4963 PMID: 25597410

[25] DuM, ShiD, YuanL, et al. . Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep, 2015, 5: 10437 PMID: 26014226 PMCID: 4444850

[26] ZhangYJ, XuF, ZhangYJ, et al. . miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9. Int J Clin Exp Med, 2015, 8(6): 9107-9113 PMID: 26309565 PMCID: 4538070

[27] ChenQY, JiaoDM, WangJ, et al. . miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Oncotarget, 2016, 21: 8229

[28] WangXW, XiXQ, WuJ, et al. . MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. Oncol Rep, 2015, 33(3): 1402-1410 PMID: 25607234

[29] KimuraSH, TsurugaH, YabutaN, et al. . Structure, expression, and chromosomal localization of human GAK. Genomics, 1997, 44(2): 179-187 PMID: 9299234

[30] AhleS, UngewickellE. Auxilin, a newly identified clathrin-associated protein in coated vesicles from bovine brain. J Cell Biol, 1990, 111(1): 19-29 PMID: 1973169

[31] RayMR, WafaLA, ChengH, et al. . Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer. Int J Cancer, 2006, 118(5): 1108-1119 PMID: 16161052

[32] GarzonR, PichiorriF, PalumboT, et al. . MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene, 2007, 26: 4148-4157 PMID: 17260024